[Autologous bone marrow transplantation in a case of Burkitt's lymphoma]. 1985

K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto

UI MeSH Term Description Entries
D008297 Male Males
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
October 1987, Minerva pediatrica,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
February 1986, Clinics in haematology,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
January 1985, IARC scientific publications,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
April 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
February 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
November 1985, Revue francaise de transfusion et immuno-hematologie,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
October 1997, Blood,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
January 1985, IARC scientific publications,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
June 1987, The New England journal of medicine,
K Yamada, and K Shinohara, and M Inoue, and Y Fujii, and Y Yoshizaki, and T Kaneko, and N Matsumoto
January 1990, The American journal of medicine,
Copied contents to your clipboard!